190 related articles for article (PubMed ID: 17427007)
1. [Genetic immunization: new ways for protective and therapeutic vaccines against allergic diseases].
Scheiblhofer S; Weiss R; Thalhamer J
Wien Med Wochenschr; 2007; 157(5-6):111-5. PubMed ID: 17427007
[TBL] [Abstract][Full Text] [Related]
2. Is genetic vaccination against allergy possible?
Weiss R; Scheiblhofer S; Gabler M; Ferreira F; Leitner WW; Thalhamer J
Int Arch Allergy Immunol; 2006; 139(4):332-45. PubMed ID: 16534215
[TBL] [Abstract][Full Text] [Related]
3. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
[TBL] [Abstract][Full Text] [Related]
4. Design of protective and therapeutic DNA vaccines for the treatment of allergic diseases.
Weiss R; Hammerl P; Hartl A; Hochreiter R; Leitner WW; Scheiblhofer S; Thalhamer J
Curr Drug Targets Inflamm Allergy; 2005 Oct; 4(5):585-97. PubMed ID: 16248827
[TBL] [Abstract][Full Text] [Related]
5. [DNA vaccines against allergy].
Sato Y; Kasukawa R
Nihon Rinsho; 2000 Jun; 58(6):1307-14. PubMed ID: 10879058
[TBL] [Abstract][Full Text] [Related]
6. DNA-based approaches to the treatment of allergies.
Spiegelberg HL; Raz E
Curr Opin Mol Ther; 2002 Feb; 4(1):64-71. PubMed ID: 11883696
[TBL] [Abstract][Full Text] [Related]
7. The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine.
Weinberger EE; Isakovic A; Scheiblhofer S; Ramsauer C; Reiter K; Hauser-Kronberger C; Thalhamer J; Weiss R
Vaccine; 2013 Dec; 31(51):6113-21. PubMed ID: 23954383
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines.
Scheiblhofer S; Gabler M; Leitner WW; Bauer R; Zoegg T; Ferreira F; Thalhamer J; Weiss R
Allergy; 2006 Jul; 61(7):828-35. PubMed ID: 16792580
[TBL] [Abstract][Full Text] [Related]
9. Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.
Draghi M; Jarman ER; Grifantini R; Galli-Stampino L; Lamb JR; Valiante NM; Grandi G
Eur J Immunol; 2002 Dec; 32(12):3720-8. PubMed ID: 12516566
[TBL] [Abstract][Full Text] [Related]
10. Deviation of the allergic IgE to an IgG response by gene immunotherapy.
Raz E; Spiegelberg HL
Int Rev Immunol; 1999; 18(3):271-89. PubMed ID: 10614729
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of an IgE response to bovine beta-lactoglobulin by gene immunization in mice].
Adel-Patient K; Créminon Ch; Boquet D; Wal JM; Chatel JM
Allerg Immunol (Paris); 2002 Mar; 34(3):77-81. PubMed ID: 12012791
[TBL] [Abstract][Full Text] [Related]
12. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
Becker Y
Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
[TBL] [Abstract][Full Text] [Related]
13. Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination.
Ludwig-Portugall I; Montermann E; Kremer A; Reske-Kunz AB; Sudowe S
J Allergy Clin Immunol; 2004 Oct; 114(4):951-7. PubMed ID: 15480341
[TBL] [Abstract][Full Text] [Related]
14. [DNA vaccines to allergic diseases and upcoming clinical application].
Sano K
Nihon Rinsho; 2005 May; 63 Suppl 5():73-9. PubMed ID: 15954328
[No Abstract] [Full Text] [Related]
15. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy.
Sudowe S; Montermann E; Steitz J; Tüting T; Knop J; Reske-Kunz AB
Gene Ther; 2002 Jan; 9(2):147-56. PubMed ID: 11857073
[TBL] [Abstract][Full Text] [Related]
16. Protective and therapeutic DNA vaccination against allergic diseases.
Isakovic A; Weiss R; Thalhamer J; Scheiblhofer S
Methods Mol Biol; 2014; 1143():243-58. PubMed ID: 24715292
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of allergic inflammation in the lung by plasmid DNA allergen immunization.
Spiegelberg HL; Broide D; Tighe H; Roman M; Raz E
Pediatr Pulmonol Suppl; 1999; 18():118-21. PubMed ID: 10093118
[TBL] [Abstract][Full Text] [Related]
18. Bicistronic expression plasmid encoding allergen and anti-IgE single chain variable fragment antibody as a novel DNA vaccine for allergy therapy and prevention.
Bandbon Balenga NA; Thalhamer J; Weiss R
Med Hypotheses; 2006; 67(1):71-4. PubMed ID: 16513289
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines for allergy treatment.
Weiss R; Scheiblhofer S; Thalhamer J
Methods Mol Med; 2006; 127():253-67. PubMed ID: 16988459
[TBL] [Abstract][Full Text] [Related]
20. DNA immunotherapeutics: new potential treatment modalities for allergic disease.
Goodman JS; Van Uden JH; Kobayashi H; Broide D; Raz E
Int Arch Allergy Immunol; 1998 Jul; 116(3):177-87. PubMed ID: 9693265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]